Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1998 Mar;82(3):245–251. doi: 10.1136/bjo.82.3.245

Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis

J Ongkosuwito 1, A Van der Lelij 1, M Bruinenberg 1, M W Doorn 1, E Feron 1, C Hoyng 1, R J W de Keizer 1, A Klok 1, A Kijlstra 1
PMCID: PMC1722535  PMID: 9602620

Abstract

AIMS—To investigate whether routine testing for Epstein-Barr virus (EBV) is necessary in the examination of a patient with uveitis.
METHODS—Intraocular EBV DNA was determined in 183 ocular fluid samples taken from patients with AIDS and uveitis, HIV negative immunocompromised uveitis, acute retinal necrosis, toxoplasma chorioretinitis, intraocular lymphoma, anterior uveitis, and miscellaneous uveitis of unknown cause. In 82 samples from this group of patients paired serum/ocular fluid analysis was performed to detect local antibody production against EBV. Controls (n=46) included ocular fluid samples taken during surgery for diabetic retinopathy, macular pucker, or cataract.
RESULTS—Serum antibody titres to EBV capsid antigen proved to be significantly increased in HIV negative immunocompromised patients with uveitis (p<0.01) compared with controls. Local antibody production revealed only three positive cases out of 82 patients tested, two results were borderline positive and one patient had uveitis caused by VZV. EBV DNA was detected in three out of 46 control ocular fluid samples. In the different uveitis groups EBV DNA was noted, but was not significantly higher than in the controls, except in six out of 11 HIV negative immunocompromised patients (p=0.0008). In four out of these six cases another infectious agent (VZV, HSV, CMV, or Toxoplasma gondii) had previously been identified as the cause of the uveitis.
CONCLUSIONS—When comparing various groups of uveitis patients, EBV DNA was found more often in HIV negative immunocompromised patients with uveitis. Testing for EBV does not have to be included in the routine management of patients with uveitis, since indications for an important role of this virus were not found in the pathogenesis of intraocular inflammation.

 Keywords: Epstein-Barr virus; intraocular fluid; polymerase chain reaction; uveitis

Full Text

The Full Text of this article is available as a PDF (152.5 KB).

Figure 1  .

Figure 1  

Open in a new tab

Serum titres against EBV as measured by immunofluorescence assay. †p value calculated by Fisher's exact test = 0.001. 

Figure 2  .

Figure 2  

Open in a new tab

Comparative detection of EBV DNA and β globin DNA detection in ocular fluid and PBL sample from two patients positive for EBV DNA in both ocular fluid and PBL sample. Patient A: HIV positive immunocompromised patient; patient B: HIV negative immunocompromised patient (no 5). 1, ocular fluid sample; 2, PBL sample, diluted 1:100; 3, PBL sample undiluted (not tested for β globin).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benjamin D., Park C. D., Sharma V. Human B cell interleukin 10. Leuk Lymphoma. 1994 Jan;12(3-4):205–210. doi: 10.3109/10428199409059591. [DOI] [PubMed] [Google Scholar]
  2. Bernasconi O. R., Herbort C. P. Atteintes oculaires par le virus d'Epstein-Barr: un diagnostic difficile. Klin Monbl Augenheilkd. 1994 May;204(5):340–343. doi: 10.1055/s-2008-1035553. [DOI] [PubMed] [Google Scholar]
  3. Birx D. L., Redfield R. R., Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med. 1986 Apr 3;314(14):874–879. doi: 10.1056/NEJM198604033141403. [DOI] [PubMed] [Google Scholar]
  4. Bloch-Michel E., Nussenblatt R. B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987 Feb 15;103(2):234–235. doi: 10.1016/s0002-9394(14)74235-7. [DOI] [PubMed] [Google Scholar]
  5. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495–503. doi: 10.1128/jcm.28.3.495-503.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chodosh J., Gan Y. J., Sixbey J. W. Detection of Epstein-Barr virus genome in ocular tissues. Ophthalmology. 1996 Apr;103(4):687–690. doi: 10.1016/s0161-6420(96)30632-5. [DOI] [PubMed] [Google Scholar]
  7. Cinque P., Brytting M., Vago L., Castagna A., Parravicini C., Zanchetta N., D'Arminio Monforte A., Wahren B., Lazzarin A., Linde A. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 1993 Aug 14;342(8868):398–401. doi: 10.1016/0140-6736(93)92814-a. [DOI] [PubMed] [Google Scholar]
  8. Grossniklaus H. E., Aaberg T. M., Purnell E. W., Luka J., Seemayer T. A. Retinal necrosis in X-linked lymphoproliferative disease. Ophthalmology. 1994 Apr;101(4):705–709. doi: 10.1016/s0161-6420(94)31275-9. [DOI] [PubMed] [Google Scholar]
  9. Holland G. N. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994 May 15;117(5):663–667. doi: 10.1016/s0002-9394(14)70075-3. [DOI] [PubMed] [Google Scholar]
  10. Longo M. C., Berninger M. S., Hartley J. L. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene. 1990 Sep 1;93(1):125–128. doi: 10.1016/0378-1119(90)90145-h. [DOI] [PubMed] [Google Scholar]
  11. Matoba A. Y. Ocular disease associated with Epstein-Barr virus infection. Surv Ophthalmol. 1990 Sep-Oct;35(2):145–150. doi: 10.1016/0039-6257(90)90069-8. [DOI] [PubMed] [Google Scholar]
  12. Pflugfelder S. C., Crouse C., Pereira I., Atherton S. Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjögren's syndrome patients. Ophthalmology. 1990 Aug;97(8):976–984. doi: 10.1016/s0161-6420(90)32476-4. [DOI] [PubMed] [Google Scholar]
  13. Pflugfelder S. C., Huang A., Crouse C. Epstein-Barr virus keratitis after a chemical facial peel. Am J Ophthalmol. 1990 Nov 15;110(5):571–573. doi: 10.1016/s0002-9394(14)77888-2. [DOI] [PubMed] [Google Scholar]
  14. Preiksaitis J. K., Diaz-Mitoma F., Mirzayans F., Roberts S., Tyrrell D. L. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis. 1992 Nov;166(5):986–994. doi: 10.1093/infdis/166.5.986. [DOI] [PubMed] [Google Scholar]
  15. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  16. Spaide R. F., Sugin S., Yannuzzi L. A., DeRosa J. T. Epstein-Barr virus antibodies in multifocal choroiditis and panuveitis. Am J Ophthalmol. 1991 Oct 15;112(4):410–413. doi: 10.1016/s0002-9394(14)76249-x. [DOI] [PubMed] [Google Scholar]
  17. Straus S. E., Cohen J. I., Tosato G., Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 1993 Jan 1;118(1):45–58. doi: 10.7326/0003-4819-118-1-199301010-00009. [DOI] [PubMed] [Google Scholar]
  18. Sunakawa M., Okinami S. Epstein-Barr virus-related antibody pattern in uveitis. Jpn J Ophthalmol. 1985;29(4):423–428. [PubMed] [Google Scholar]
  19. Tiedeman J. S. Epstein-Barr viral antibodies in multifocal choroiditis and panuveitis. Am J Ophthalmol. 1987 May 15;103(5):659–663. doi: 10.1016/s0002-9394(14)74325-9. [DOI] [PubMed] [Google Scholar]
  20. Tosato G., Steinberg A. D., Yarchoan R., Heilman C. A., Pike S. E., De Seau V., Blaese R. M. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest. 1984 Jun;73(6):1789–1795. doi: 10.1172/JCI111388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tsai C. S., Ritch R., Straus S. E., Perry H. D., Hsieh F. Y. Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome. Arch Ophthalmol. 1990 Nov;108(11):1572–1576. doi: 10.1001/archopht.1990.01070130074034. [DOI] [PubMed] [Google Scholar]
  22. Usui M., Sakai J. Three cases of EB virus-associated uveitis. Int Ophthalmol. 1990 Oct;14(5-6):371–376. doi: 10.1007/BF00163559. [DOI] [PubMed] [Google Scholar]
  23. Vieira P., de Waal-Malefyt R., Dang M. N., Johnson K. E., Kastelein R., Fiorentino D. F., deVries J. E., Roncarolo M. G., Mosmann T. R., Moore K. W. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1172–1176. doi: 10.1073/pnas.88.4.1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wong K. W., D'Amico D. J., Hedges T. R., 3rd, Soong H. K., Schooley R. T., Kenyon K. R. Ocular involvement associated with chronic Epstein-Barr virus disease. Arch Ophthalmol. 1987 Jun;105(6):788–792. doi: 10.1001/archopht.1987.01060060074036. [DOI] [PubMed] [Google Scholar]
  25. de Boer J. H., Verhagen C., Bruinenberg M., Rothova A., de Jong P. T., Baarsma G. S., Van der Lelij A., Ooyman F. M., Bollemeijer J. G., Derhaag P. J. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 1996 Jun;121(6):650–658. doi: 10.1016/s0002-9394(14)70631-2. [DOI] [PubMed] [Google Scholar]
  26. van Gorp J., Doornewaard H., Verdonck L. F., Klöpping C., Vos P. F., van den Tweel J. G. Posttransplant T-cell lymphoma. Report of three cases and a review of the literature. Cancer. 1994 Jun 15;73(12):3064–3072. doi: 10.1002/1097-0142(19940615)73:12<3064::aid-cncr2820731227>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES